Epithalon for Sale

Epithalon for sale is a search that returns hundreds of pages carrying almost no checkable information, and the difference between a real listing and a decorated one comes down to seven lines of text. None of them is the price.

This page reads a listing the way you would read a delivery note, then follows the same claims through to the vial that turns up days later. Everything described is research material for laboratory use and not for human consumption, and the supplier links below are affiliate links.

The listing checked against these criteria at the end is this one.

Epithalon for sale: the seven lines a listing owes you

The form. Lyophilised powder, solution, capsule or nasal spray are four different products with four different sterility stories, and a listing that only says "peptide" has skipped the most consequential fact about what it is selling. A sealed vial of freeze-dried powder is the format that keeps longest and the format the testing conventions in this market were built around.

The quantity, and what kind of number it is. A listing states 10 mg. That is a label target. A listing that also states what a laboratory measured has given you a second, different number, and the gap between them is real information rather than an error.

The batch or lot number. This is the load-bearing line. It is the only element on a product page that has to come from physical stock rather than from a keyboard, and it is what converts a certificate from a decoration into a document about your vial.

The testing scope, named test by test. "Third-party tested" is a phrase, not a scope. Purity, identity, endotoxin, sterility and heavy metals are five separate tests, and a listing that says which of them were run is telling you what the seller knows and, more usefully, what it does not.

The storage. Sealed lyophilised material and reconstituted material are stored differently, and a listing that states both has demonstrated it understands what it ships. A listing silent on storage is usually silent because the copy was written from a template.

The research-use statement. Material of this kind is sold for laboratory use rather than for administration to a person. A listing that says so plainly, and then does not undercut it two paragraphs later with a suggested protocol, is internally consistent. Many are not.

The price mechanics. List price, discount mechanism, what quantity tiers do, and where free shipping starts. Every one of those is knowable before you pay, and a listing that obscures any of them is choosing to.

The substitutions that appear when those lines are missing

Weak listings do not leave blank space. They fill it, and the fillers are consistent enough to recognise on sight.

A purity percentage asserted in body copy with no document behind it. A laboratory name mentioned without a report, which is the most common single trick in the category. A stock photograph of an unlabelled vial, sometimes the same photograph across six competing storefronts. A generic product-level PDF, undated and carrying no lot number, republished for every shipment for as long as the page has existed.

And the one that reverses the intended effect entirely: dosing guidance. A protocol on a research-use listing contradicts the basis of the sale on the same page, and it is worth treating as a signal about the seller rather than as a helpful extra.

Where the measured fill weight does the most work

Of the seven lines, the one that separates listings most sharply on this compound is the quantity, and there is a published example worth reading.

The certificate for batch 15-05260628, report KVR-2026-A36FF4 from Kovera Labs, certified 05/23/2026, reports 99.312% purity against a specification of 98 percent or better, identity confirmed by LC-MS, an endotoxin safety screen passing against a limit of 0.5 EU/mL, a microbial sterility screen with no growth, and heavy metals screening returning negative for arsenic, cadmium, lead and mercury. The analytical method is named as RP-HPLC on a C18 column with detection at 214 nm, and the report prints an access code for the laboratory's own verification portal.

Then it states net content: 9.64 mg, against a 10 mg label, with the specification written as 10 mg plus or minus 10 percent.

That is inside tolerance and under the label, and it is the most useful line in the whole document precisely because it is unflattering. It moves the honest price on that batch from $2.50 per milligram to $2.59. A seller that prints a number working slightly against its own listing has demonstrated something about how it handles documents that no marketing sentence demonstrates, and the demonstration only exists because the measurement was published.

Two cautions to keep it the right size. The figure describes that lot rather than the next one, and fill weights land on either side of a label across batches, so this is not a permanent property of the product. And a clean panel is a statement about powder, not about people.

Commercially the same listing reads: $50.00 list, reduced from $69.99, $25.00 with the code PEPTIDEDECK, tiers of 3, 5 or 10 vials taking 3%, 5% or 10% off list with no published indication that they stack with the code, and free shipping from $250.

What actually arrives, checked against what was written

A week is the usual gap between reading the listing and holding the object, and it is the point where the seven lines stop being claims.

What lands is a small glass vial with a crimped seal, holding a white or off-white lyophilised cake that occupies far less of the vial than people expect. On the published batch the cap is red and the crimp silver. The label carries the compound name, the quantity and a lot number, and nothing on the packaging implies human use.

Three checks take a minute. The lot number on the label should be the batch number on the certificate, not merely a plausible-looking code. The contents should be a dry cake rather than a liquid or a loose powder sliding around the vial. And the seal should be intact, because a crimp that has been disturbed ends the sterility conversation regardless of what any report says.

If a line disagrees, raise it before opening anything. An unopened vial is a much shorter conversation with a seller than an opened one, and this is the one moment in the whole transaction where you have leverage.

One line from the listing you cannot verify at home is the regulatory position, so it is worth stating here. Epitalon, as FDA and PubChem spell it, has no FDA approval anywhere in the West, and it sits on no current FDA category list: it was nominated as a bulk drug substance, placed in category 2 under the interim policies, and then withdrawn, so it now appears in the agency's table of substances nominated but withdrawn. It also has no applicable USP monograph and is not a component of an approved drug, which closes the compounding route under 21 CFR 216.23. A listing claiming otherwise has failed a check you can run without leaving the page.

Common questions

Keep exploring

The same line-by-line reading applied to a lot that assayed over its label instead of under it is the Selank listing checked before the cart, and the contrast between an overfilled vial and this one is the clearest illustration of why the measurement matters more than its direction. For the version where the listing and the delivered object disagree most often, what the NAD+ listing says against what the vial shows is the closest parallel. And which BPC-157 format survives the trip covers the first of the seven lines in far more depth.